Nuvig Therapeutics Funding: $208M Raised, Series B (2024)
Nuvig Therapeutics is based in Palo Alto, California. It has raised $208M in total funding. Latest round: Series B.
Nuvig Therapeutics funding overview
Nuvig Therapeutics is based in Palo Alto, California. Nuvig Therapeutics has raised $208M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in December 2024. The round record for Nuvig Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Novo Holdings A/S, Platanus, Bristol Myers Squibb, Digitalis Ventures, Mission BioCapital, Sanofi Ventures and 7 others. 13 distinct backers are named across the disclosed rounds.
Nuvig Therapeutics at a glance
Total raised
$208M
Latest round
Series B
Latest round date
December 2024
Headquarters
Palo Alto, California
Notable investors
Novo Holdings A/S, Platanus, Bristol Myers Squibb, Digitalis Ventures, Mission BioCapital, Sanofi Ventures, Blue Owl Healthcare Opportunities, Norwest Venture Partners
Frequently asked about Nuvig Therapeutics funding
How much has Nuvig Therapeutics raised?
Nuvig Therapeutics has raised $208M in total disclosed funding across the rounds on record.
Who has invested in Nuvig Therapeutics?
Novo Holdings A/S, Platanus, Bristol Myers Squibb, Digitalis Ventures, Mission BioCapital, Sanofi Ventures are named among the investors backing Nuvig Therapeutics.
What was the latest Nuvig Therapeutics funding round?
The most recent disclosed round is a Series B, announced in December 2024.
Where is Nuvig Therapeutics based?
Nuvig Therapeutics is based in Palo Alto, California.
When did Nuvig Therapeutics last raise?
The last disclosed Nuvig Therapeutics round closed in December 2024 at Series B.
Every Nuvig Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Palo Alto at a similar stage.
